Companies / Corcept Therapeutics Inc
Corcept Therapeutics Inc
Financials · FY2025
Ownership
108.1M shares outstanding · as of Jul 22, 2026
Ownership
| Insiders | 10.06% | 10,875,642 |
| 10%+ / strategic | 12.05% | 13,021,994 |
| Institutions | 64.39% | 69,604,174 |
| Public float | 13.50% | 14,596,587 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Baker G Leonard JrDirector | 5.13% | 5,550,196 |
Belanoff Joseph KCEOChief Executive Officer · Director | 2.65% | 2,865,489 |
Mahoney David LDirector | 1.17% | 1,263,292 |
Wilson James NDirector | 1.01% | 1,094,543 |
Hunt HazelFormerChief Scientific Officer | 0.24% | 255,437 |
Maduck SeanSee Remarks | 0.04% | 43,755 |
Robb Gary CharlesChief Business Officer | 0.04% | 38,252 |
Mokari AtabakChief Financial Officer | 0.01% | 16,130 |
Lyon Joseph DouglasFormerSee Remarks | <0.01% | 7,035 |
Guyer WilliamChief Development Officer | <0.01% | 3,985 |
Institutional holders 405
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.08B | 11.50% | |
| $330.42M | 8.78% | |
| $285.15M | 3.03% | |
| $229.07M | 5.26% | |
| $134.99M | 3.59% | |
| $109.40M | 2.51% | |
| $87.61M | 2.01% | |
| $84.03M | 2.23% | |
| $60.47M | 1.39% | |
| $56.58M | 1.50% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | First Trust Advisors LP 13F manager | Add | — | $59.66M | +1.5M +213.48% | 2,173,376 2.01% of shares | high |
| Q1 2026 as of | Tang Capital Management, LLC 13F manager | Add | — | $54.15M | +1.3M +856.85% | 1,500,000 1.39% of shares | high |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | — | $40.78M | +1.0M +596.27% | 1,181,348 1.09% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $37.00M | +918K +3283.11% | 945,884 0.88% of shares | medium |
| Q1 2026 as of | TD Asset Management Inc 13F manager | Exit | — | $-34.62M | -995K -100.00% | — | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $32.16M | +370K +3.07% | 12,432,023 11.50% of shares | medium |
| Q1 2026 as of | Epoch Investment Partners, Inc. 13F manager | Exit | — | $-28.42M | -817K -100.00% | — | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $25.51M | +293K +9.82% | 3,279,381 3.03% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Renaissance Technologies LLC | Passive13G/A | — |
| INGALLS & SNYDER LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CORT | — | 218352102 |